| Name | Minnequa Medicenter |
|---|---|
| Location | 2701 California St, Pueblo, Colorado |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 106 |
| Occupancy Rate | 65.47% |
| Medicare ID (CCN) | 065229 |
| Legal Business Name | Ssc Pueblo Operating Company Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1679164768 |
| Organization Name | PUEBLO NURSING AND REHAB CENTER, LLC |
| Address | 2701 California St, Pueblo, CO 81004 |
| Phone Number | 801-601-1450 |
News Archive
According to widely reported community-based research, almost half the U.S. population suffers from depression. But research by two sociologists indicates that percentage is greatly exaggerated or is a misrepresentation.
Uroplasty, Inc. (Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results published in the September, 2009 edition of THE JOURNAL OF UROLOGY(R) from the OrBIT trial of its Urgent PC System.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Scientists have developed a process that improves the efficiency of CRISPR, an up-and-coming technology used to edit DNA.
› Verified 4 days ago
| NPI Number | 1700452711 |
| Organization Name | DESERT WILLOW HEALTH AND REHABILITATION CENTER LLC |
| Address | 2701 California St, Pueblo, CO 81004 |
| Phone Number | 719-561-1300 |
News Archive
According to widely reported community-based research, almost half the U.S. population suffers from depression. But research by two sociologists indicates that percentage is greatly exaggerated or is a misrepresentation.
Uroplasty, Inc. (Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results published in the September, 2009 edition of THE JOURNAL OF UROLOGY(R) from the OrBIT trial of its Urgent PC System.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Scientists have developed a process that improves the efficiency of CRISPR, an up-and-coming technology used to edit DNA.
› Verified 4 days ago
| NPI Number | 1881715910 |
| Organization Name | SSC PUEBLO OPERATING COMPANY LLC |
| Doing Business As | MINNEQUA MEDICENTER |
| Address | 2701 California St, Pueblo, CO 81004 |
| Phone Number | 719-561-1300 |
News Archive
According to widely reported community-based research, almost half the U.S. population suffers from depression. But research by two sociologists indicates that percentage is greatly exaggerated or is a misrepresentation.
Uroplasty, Inc. (Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results published in the September, 2009 edition of THE JOURNAL OF UROLOGY(R) from the OrBIT trial of its Urgent PC System.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Scientists have developed a process that improves the efficiency of CRISPR, an up-and-coming technology used to edit DNA.
› Verified 4 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
According to widely reported community-based research, almost half the U.S. population suffers from depression. But research by two sociologists indicates that percentage is greatly exaggerated or is a misrepresentation.
Uroplasty, Inc. (Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results published in the September, 2009 edition of THE JOURNAL OF UROLOGY(R) from the OrBIT trial of its Urgent PC System.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Scientists have developed a process that improves the efficiency of CRISPR, an up-and-coming technology used to edit DNA.
› Verified 4 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 4 |
| Total Amount of Fines in Dollars | $151659 |
| Number of Payment Denials | 1 |
| Total Number of Penalties | 5 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 19.8 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 0.8 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 30.2 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.78 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.94 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 8.92 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.12 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 93.64 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 26.34 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 93.06 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 10.26 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 34.12 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 21.43 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 1.57 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 88.71 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 68.72 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 84.21 | 82.93 |
News Archive
According to widely reported community-based research, almost half the U.S. population suffers from depression. But research by two sociologists indicates that percentage is greatly exaggerated or is a misrepresentation.
Uroplasty, Inc. (Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results published in the September, 2009 edition of THE JOURNAL OF UROLOGY(R) from the OrBIT trial of its Urgent PC System.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Scientists have developed a process that improves the efficiency of CRISPR, an up-and-coming technology used to edit DNA.
› Verified 4 days ago
Rock Canyon Respiratory And Rehabilitation Center Location: 2515 Pitman Pl, Pueblo, Colorado 81004 Phone: (719) 564-0550 | |
Belmont Lodge Health Care Center Location: 1601 Constitution Rd, Pueblo, Colorado 81001 Phone: (719) 562-7200 | |
University Park Care Center Location: 945 Desert Flower Blvd, Pueblo, Colorado 81001 Phone: (719) 545-5321 | |